Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...

Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

An American visitor in India shared her experience buying contact lenses. She purchased three pairs for just $26. This required no insuranc...

Vetic, a pet care startup, has secured $40 million in funding. This investment will fuel the expansion of its clinic network, adding 25 new...

A solo female traveler named Paige described Indians as the "most hospitable" people she has ever met during her journey across India. She ...

On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...

India's healthcare sector has seen a major transformation over the last 12 years. Health insurance coverage has expanded significantly. Mat...

The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

The Caduceus acquisition will add nearly 200 employees to Innovaccer’s rolls and open up a new avenue for the company in revenue cycle mana...

Happy Thursday! Mid-sized IT firms are realigning leadership teams as AI-driven changes force a rethink. This and more in today's ETtech Mo...

Global pharma major Bayer is significantly expanding its consumer healthcare presence in India, targeting the burgeoning self-care market e...

The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...

India's NEET (UG) 2026 exam was cancelled due to alleged paper leaks, prompting a CBI inquiry and a re-examination. This mirrors global cha...